<p> [ad_1]<br />
</p>
<div>
<div class="entry-content column content primary is-two-thirds">
<div class="" style="padding-bottom: 10px;">
<div class="">
<p>
						<span class="tag is-dark is-uppercase">Investing</span>
				</p>
<div class="byline-container">
<div class="post-date is-italic has-text-grey is-size-7 has-text-weight-medium ">
<p>January 19, 2023 10:53 pm</p>
</p></div>
</p></div>
</p></div>
</p></div>
</p></div>
<p>Mid-cap stocks are proving to be an attractive investment option over the past few years. In fact, the S&#038;P MidCap 400 index has performed better than the S&#038;P 500 and the S&#038;P SmallCap 600 index for most of the past 20 years (through 2015), according to a report by S&#038;P Global. Going forward, most analysts are expecting a good show from quality mid-cap stocks in 2023. Let’s take a look at the five best and worst performing mid-cap stocks in Q4 2022.</p>
<h2>Five Best Performing Mid-Cap Stocks In Q4 2022</h2>
<p>We have taken the fourth quarter 2022 return numbers of mid-cap stocks from finviz.com to rank the five best and worst performing mid-cap stocks in Q4 2022. Here are the five best performing mid-cap stocks in Q4 2022:</p>
<h3>5. Prometheus Biosciences (86%)</h3>
<p>Founded in 2016 and headquartered in San Diego, Calif., this company focuses on developing therapeutics and companion diagnostics for gastroenterology and autoimmune diseases. Prometheus Biosciences Inc (NASDAQ:RXDX) shares are up by almost 9% year to date and up almost 251% in the last year.</p>
<p>As of this writing, Prometheus Biosciences shares are trading above $122 with a 52-week range of $21.50 to $122.75, giving the company a market capitalization of more than $5.5 billion.</p>
<h3>4. Vaxcyte (100%)</h3>
<p>Founded in 2013 and headquartered in San Carlos, Calif., this company develops vaccines for infectious diseases. Vaxcyte Inc (NASDAQ:PCVX) shares are down by over 7% year to date but are up by over 152% in the last year.</p>
<p>As of this writing, Vaxcyte shares are trading above $44 with a 52-week range of $16.78 to $49.31, giving the company a market cap of more than $3.5 billion.</p>
<h3>3. Maxar Technologies (176%)</h3>
<p>Founded in 1969 and headquartered in Westminster, Colo., this company provides space technology solutions. Maxar Technologies Inc (NYSE:MAXR) shares are down by almost 1% year to date and up by over 89% in the last year.</p>
<p>As of this writing, Maxar Technologies shares are trading above $51 with a 52-week range of $17.51 to $51.93, giving the company a market cap of more than $3.8 billion.</p>
<h3>2. Immunovant (218%)</h3>
<p>Founded in 2018 and headquartered in New York City, this company focuses on treatments to enable normal lives for patients with autoimmune diseases. Immunovant Inc (NASDAQ:IMVT) shares are down by almost 2% year to date but are up by over 150% in the last year.</p>
<p>As of this writing, Immunovant shares are trading above $16.90 with a 52-week range of $3.15 to $20.24, giving the company a market cap of more than $2.3 billion.</p>
<h3>1. Madrigal Pharmaceuticals (347%)</h3>
<p>Founded in 2011 and headquartered in Fort Washington, Pa., this company develops therapeutic candidates for treating cardiovascular, metabolic, and liver diseases. Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) shares are up by almost 4% year to date and up over 340% in the last year.</p>
<p>As of this writing, Madrigal Pharmaceuticals shares are trading above $300 with a 52-week range of $52.33 to $315.45, giving the company a market capitalization of more than $5 billion.</p>
<h2>Five Worst Performing Mid-Cap Stocks In Q4 2022</h2>
<p>Here are the five worst performing mid-cap stocks in Q4 2022:</p>
<h3>5. Applovin (-46%)</h3>
<p>Founded in 2011 and headquartered in Palo Alto, Calif., this company operates as a mobile marketing platform. Applovin Corp (NASDAQ:APP) shares are up by almost 2% year to date but are down by almost 85% in the last year.</p>
<p>As of this writing, Applovin shares are trading above $10.40 with a 52-week range of $9.14 to $76.38, giving the company a market capitalization of more than $4 billion.</p>
<h3>4. Affirm Holdings (-48%)</h3>
<p>Founded in 2012 and headquartered in San Francisco, this company provides a platform for digital and mobile-first commerce. Affirm Holdings Inc (NASDAQ:AFRM) shares are up by over 34% year to date but are down by over 79% in the last year.</p>
<p>As of this writing, Affirm Holdings shares are trading above $12.90 with a 52-week range of $8.62 to $83.57, giving the company a market cap of more than $3.8 billion.</p>
<h3>3. Guardian Health (-50%)</h3>
<p>Founded in 2021 and headquartered in Palo Alto, Calif., it is a precision oncology company that deals in the treatment of cancer. Guardant Health Inc (NASDAQ:GH) shares are up by almost 18% year to date but are down by over 56% in the last year.</p>
<p>As of this writing, Guardant Health shares are trading $32 with a 52-week range of $24.63 to $78.34, giving the company a market cap of more than $3.1 billion.</p>
<h3>2. Rogers (-51%)</h3>
<p>Founded in 1832 and headquartered in Chandler, Ariz., this company makes and sells engineered materials and components for mission critical applications. Rogers Corp (NYSE:ROG) shares are up by almost 10% year to date but are down by over 52% in the last year.</p>
<p>As of this writing, Rogers shares are trading above $130 with a 52-week range of $98.45 to $274.51, giving the company a market cap of more than $2.4 billion.</p>
<h3>1. Rumble (-51%)</h3>
<p>Founded in 2013 and headquartered in New York City, it is an online neutral video platform. Rumble Inc (NASDAQ:RUM) shares are up by almost 68% year to date but are down by almost 21% in the last year.</p>
<p>As of this writing, Rumble shares are trading above $9.55 with a 52-week range of $5.81 to $18.52, giving the company a market capitalization of more than $3.7 billion.</p>
<p><i>This article originally appeared on ValueWalk</i></p>
<p>				<!-- #post-footer--></p></div>

5 Best and Worst Performing Mid-Cap Stocks in Q4 2022 – Darlinez News.
